ArticleMolecules (Basel, Switzerland)2018

New Drug Candidate Targeting the 4A1 Orphan Nuclear Receptor for Medullary Thyroid Cancer Therapy.

Lei Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.